CAS: 1239358-86-1 - N2-[(1S)-1-(4-Fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-2,6-pyridinediamine

Formule : C₂₁H₂₀FN₇

InChI : InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1

Code InChI : InChIKey=UQTPDWDAYHAZNT-AWEZNQCLSA-N

SMILES : FC1=CC=C(C=C1)C(NC2=NC(=CC(=C2)C=3C=NN(C3)C)NC4=NC=CN=C4)C

Synonymes :

• 2,6-Pyridinediamine, N2-[(1S)-1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-
• N2-[(1S)-1-(4-Fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-2,6-pyridinediamine
• (S)-N-[1-(4-Fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N′-(pyrazin-2-yl)pyridine-2,6-diamine
• NS 018
• Ilginatinib

Ilginatinib

CAS : 1239358-86-1

Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2.

• Formule : C₂₁H₂₀FN₇
• Degré de pureté : 98.40% - 99.43%
• Couleur et forme : Solid
• Masse moléculaire : 389.43

Ilginatinib

CAS : 1239358-86-1

Ilginatinib is a cell-factor inhibitor that has been identified as a potential therapeutic agent for …

• Formule : C₂₁H₂₀FN₇
• Degré de pureté : Min. 95%
• Masse moléculaire : 389.43 g/mol